Glenmede Trust CO Na Amneal Pharmaceuticals, Inc. Transaction History

Glenmede Trust CO Na

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$2.87 - $5.46 $327 - $622	-114 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$13.09 - $21.49 $70,227 - $115,293	-5,365 Reduced 97.92%	114 $1,000
Q3 2018 Nov 15, 2018	SELL	$16.4 - $24.27 $3,017 - $4,465	-184 Reduced 3.25%	5,479 $120,000
Q2 2018 Nov 05, 2018	SELL	$13.95 - $20.2 $376 - $545	-27 Reduced 0.47%	5,663 $93,000
Q2 2018 Aug 15, 2018	BUY	$13.95 - $20.2 $79,375 - $114,938	5,690 New	5,690 $93,000

185

141M

57K

49K

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.25B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

Stay updated on Glenmede Trust CO Na with notifications on news.